{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:44:42Z","timestamp":1793411082906,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1471,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35 CA220481"],"award-info":[{"award-number":["R35 CA220481"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["DP5 OD021403"],"award-info":[{"award-number":["DP5 OD021403"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41379-018-0127-2","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T10:19:33Z","timestamp":1535710773000},"page":"88-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42"],"prefix":"10.1016","volume":"32","author":[{"given":"Meredith","family":"Stevers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Rabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Van Ziffle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Grenert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwei","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris C.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Zaloudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-7999","authenticated-orcid":false,"given":"David A.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0127-2_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00000478-198104000-00004","article-title":"Papillary peritoneal tumors in women","volume":"5","author":"Foyle","year":"1981","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::AID-CNCR2820650218>3.0.CO;2-W","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases","volume":"65","author":"Daya","year":"1990","journal-title":"Cancer"},{"key":"10.1038\/s41379-018-0127-2_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0959-8049(95)00574-9","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a separate entity","volume":"32","author":"Hoekman","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-018-0127-2_bib4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00000478-200110000-00012","article-title":"Well-differentiated papillary mesothelioma","volume":"25","author":"Butnor","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/his.12089","article-title":"Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation","volume":"62","author":"Chen","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/s41379-018-0127-2_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jjco\/hyt117","article-title":"Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum","volume":"43","author":"Lee","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1038\/s41379-018-0127-2_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00000478-200404000-00013","article-title":"Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases","volume":"28","author":"Galateau-Salle","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib9","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/modpathol.2010.113","article-title":"Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential","volume":"23","author":"Brimo","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib10","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1309\/2H0NVRERPP2LJDUA","article-title":"Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis","volume":"123","author":"Baker","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAT.0b013e3283631cce","article-title":"Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy","volume":"45","author":"Lee","year":"2013","journal-title":"Pathology"},{"key":"10.1038\/s41379-018-0127-2_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAT.0000000000000181","article-title":"Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients","volume":"46","author":"Liu","year":"2014","journal-title":"Pathology"},{"key":"10.1038\/s41379-018-0127-2_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PGP.0000000000000146","article-title":"Selected topics in peritoneal pathology","volume":"33","author":"Baker","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2016.188","article-title":"Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X","volume":"30","author":"Joseph","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2017.153","article-title":"Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation","volume":"31","author":"Goode","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1038\/s41379-018-0127-2_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Reuss","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1038\/s41379-018-0127-2_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.24854","article-title":"Genomic analysis reveals frequent TRAF7 mutations in intraneural perineuriomas","volume":"81","author":"Klein","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1038\/s41379-018-0127-2_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-018-0127-2_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma","volume":"13","author":"Alakus","year":"2015","journal-title":"J Transl Med"},{"key":"10.1038\/s41379-018-0127-2_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-018-0127-2_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant peritoneal mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1038\/s41379-018-0127-2_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology","volume":"28","author":"Andrici","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","article-title":"BAP1 is altered by copy number loss, mutation, and\/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas","volume":"12","author":"Leblay","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-018-0127-2_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/dc.23837","article-title":"Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions","volume":"46","author":"Cozzi","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-018-0127-2_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PAS.0000000000000976","article-title":"Loss of BAP1 expression in atypical mesothelial proliferations helps to predict malignant mesothelioma","volume":"42","author":"Pillappa","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0127-2_bib29","doi-asserted-by":"crossref","unstructured":"Lee HE, Molina JR, Sukov WR, Roden AC, Yi ES. BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma. Hum Pathol. 2018 May 12 [Epub ahead of print].","DOI":"10.1016\/j.humpath.2018.05.001"},{"key":"10.1038\/s41379-018-0127-2_bib30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcp.25676","article-title":"The emerging role of TRAF7 in tumor development","volume":"232","author":"Zotti","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1038\/s41379-018-0127-2_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-kB signaling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"key":"10.1038\/s41379-018-0127-2_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/neuonc\/now025","article-title":"Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling","volume":"18","author":"Figarella-Branger","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1038\/s41379-018-0127-2_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1440-1827.2011.02720.x","article-title":"Combined adenomatoid tumor and well differentiated papillary mesothelioma of the omentum","volume":"61","author":"Hatano","year":"2011","journal-title":"Pathol Int"},{"key":"10.1038\/s41379-018-0127-2_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.111.1.143","article-title":"Molecular characterization of CDC42, a Saccharomyces cerevisiae gene involved in the development of cell polarity","volume":"111","author":"Johnson","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1038\/s41379-018-0127-2_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0092-8674(95)90370-4","article-title":"Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia","volume":"81","author":"Nobes","year":"1995","journal-title":"Cell"},{"key":"10.1038\/s41379-018-0127-2_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1101\/gad.11.4.463","article-title":"Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins","volume":"11","author":"Perona","year":"1997","journal-title":"Genes Dev"},{"key":"10.1038\/s41379-018-0127-2_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.7652575","article-title":"An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1","volume":"269","author":"Olson","year":"1995","journal-title":"Science"},{"key":"10.1038\/s41379-018-0127-2_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1038\/s41379-018-0127-2_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-018-0127-2_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-018-0127-2_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-018-0127-2_bib42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat Genet"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0127-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0127-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0127-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:45:15Z","timestamp":1760229915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222011073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0893395222011073"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0127-2","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0127-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}